A nanofiber membrane scaffold for regeneration of periodontal bone defects and a preparation method thereof

By using electrospinning in the periodontal bone defect area, the nanofiber membrane scaffold was covered with the load growth factor of the polydopamine layer, the problems of unstable growth factor release and limited metal ion activation in the prior art were solved, and the teeth were realized Effective regeneration and functional reconstruction of Zhou tissue.

CN118649290BActive Publication Date: 2024-12-03NANKAI UNIV
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411114077.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2024-08-14
Publication Date
2024-12-03
Estimated Expiration
2044-08-14

AI Technical Summary

Technical Problem

The existing periodontal tissue regeneration stents are unstable in the release of growth factors and have limited metal ion activation, making it difficult to effectively promote periodontal tissue regeneration.

Method used

Using nanofiber membrane scaffolds, nanofiber membranes are prepared through electrospinning technology, and the polydopamine layer is covered on its surface, loading force growth factor (MGF), forming amide bonds to achieve long-term stable release, regulating the local immune microenvironment, and promoting dental Regeneration of the weekly tissue.

Benefits of technology

Long-term continuous delivery of force growth factors is achieved, biomechanical stimulation is simulated, periodontal stem cells are promoted osteogenesis and differentiation, inhibit osteoclast activation, improve the inflammatory microenvironment, and effectively promote periodontal bone regeneration.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118649290B_ABST
    Figure CN118649290B_ABST
Patent Text Reader

Abstract

The present invention relates to the technical field of tissue engineering materials, and discloses a nanofiber membrane scaffold for periodontal bone defect regeneration and a preparation method thereof, wherein the scaffold comprises a nanofiber membrane, and the nanofiber membrane is covered with a polydopamine layer, and the surface of the polydopamine layer is loaded with a strong growth factor. The present invention aims to provide a nanofiber membrane and a preparation method thereof that can stably release growth factors for a long time, improve the local inflammatory microenvironment, simulate biomechanical signals, promote osteogenic differentiation of stem cells, regulate the osteoblast-osteoclast level, and then mediate bone regeneration at the periodontal defect site.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of tissue engineering materials, and in particular to a nanofiber membrane scaffold for regeneration of periodontal bone defects and a preparation method thereof. Background Art

[0002] Periodontitis is a common chronic inflammatory disease in the oral cavity. For patients with periodontitis who have periodontal bone defects, conventional periodontal treatment methods are difficult to achieve effective periodontal tissue regeneration and reconstruction of the structure and function of periodontal tissues. The long-term inflammatory microenvironment at the site of periodontal defects is not only not conducive to the proliferation and differentiation of stem cells, but also leads to increased osteoclast activity and weakened osteogenesis in the alveolar bone, which poses a huge challenge to periodontal tissue regeneration based on tissue engineering technology.

[0003] In the prior art, the preparation of scaffolds for treating patients is often used, but there are still certain problems. For example, tissue engineering scaffolds used for periodontal tissue regeneration are mostly loaded with growth factors directly on the scaffolds by solution immersion. This physical loading method is not conducive to the long-term stable release of growth factors. In the prior art, metal ions (such as magnesium ions and zinc ions) are also often used to activate osteoblasts, but the activation effect is limited, resulting in metal ions being difficult to fully mobilize the initiative of cells and difficult to promote periodontal tissue regeneration. Summary of the invention

[0004] In order to solve the above technical problems, the present invention provides a nanofiber membrane scaffold for periodontal bone defect regeneration. The scaffold of the present invention can continuously deliver force-stimulating growth factors to the periodontal bone defect area for a long time, while exerting anti-inflammatory and osteogenesis-promoting effects, effectively promoting periodontal tissue regeneration and rebuilding periodontal tissue function.

[0005] The present invention provides a nanofiber membrane scaffold for regeneration of periodontal bone defects. The scaffold comprises a nanofiber membrane. The nanofiber membrane is covered with a polydopamine layer. The surface of the polydopamine layer is loaded with mechano growth factor (MGF).

[0006] Furthermore, the amine group of the polydopamine layer forms an amide bond with the carboxyl group of the mechano-growth factor.

[0007] Furthermore, the loading rate of the mechano-growth factor in the nanofiber membrane scaffold is not less than 86%.

[0008] Furthermore, the average pore diameter of the nanofiber membrane is 1.4 μm-1.8 μm.

[0009] The present invention also provides a method for preparing a nanofiber membrane scaffold for regeneration of periodontal bone defects, the preparation method comprising:

[0010] S1: obtaining an electrospinning solution, injecting the electrospinning solution into a syringe, injecting, preparing a nanofiber membrane by an electrospinning method, and drying the collected nanofiber membrane;

[0011] S2: soaking the dried nanofiber membrane in a dopamine solution, washing, and drying;

[0012] S3: Soak the S2 dopamine-modified nanofiber membrane in a force growth factor solution, incubate, and obtain a nanofiber membrane scaffold.

[0013] Furthermore, the preparation of the electrospinning solution includes mixing the first organic polymer material, the second organic polymer material and an organic solvent.

[0014] Furthermore, the organic solvent includes one or more of N,N-dimethylformamide (DMF), dichloromethane, chloroform, deuterated chloroform, tetrahydrofuran, methanol, ethanol, and chloroform.

[0015] More preferably, the organic solvent consists of chloroform and methanol; the volume ratio of chloroform to methanol is 5:1.

[0016] Furthermore, the mass ratio of the first organic polymer material to the second organic polymer material is 7:3.

[0017] Furthermore, the sum of the mass concentrations of the first organic polymer material and the second organic polymer material in the electrospinning solution is 12%.

[0018] Furthermore, the first organic polymer material includes polycaprolactone.

[0019] Furthermore, the second organic polymer material includes one or more of polylactic acid-glycolic acid, polylactic acid (PLA), and polyglycolic acid (PGA).

[0020] Furthermore, the injection speed in S1 is 0.9 mL / h-1.1 mL / h.

[0021] More preferably, the injection rate in S1 is 1 mL / h.

[0022] Furthermore, the specific conditions of the electrospinning method in S1 include a voltage of 15 kV-18 kV, a receiving distance of 17 cm-19 cm, a temperature of 24° C.-26° C., a humidity of 34%-36%, and an electrospinning time of 0.9 h-1.1 h.

[0023] Further preferably, the specific conditions of the electrospinning method in S1 include a voltage of 15 kV, a receiving distance of 18 cm, a temperature of 24° C.-26° C., a humidity of 34%-36%, and an electrospinning time of 0.9 h-1.1 h.

[0024] Furthermore, the drying temperature in S1 is 24° C.-26° C., and the drying time is 23 h-25 h.

[0025] Furthermore, the preparation method of the dopamine solution in S2 includes placing dopamine in a Tris-HCl buffer solution, wherein the pH value of the Tris-HCl buffer solution is 10-11.

[0026] Furthermore, the preparation method of the Tris(hydroxymethyl)aminomethane hydrochloride buffer solution is specifically as follows: dispersing Tris(hydroxymethyl)aminomethane hydrochloride) in deionized water, and adjusting the pH value of the Tris(hydroxymethyl)aminomethane hydrochloride buffer solution.

[0027] Furthermore, the molar concentration of the Tris hydrochloride buffer is 9 mM-11 mM.

[0028] Furthermore, the mass concentration of dopamine in the dopamine solution is 2 mg / mL.

[0029] Furthermore, the drying temperature in S2 is 24° C.-26° C., and the drying time is 23 h-25 h.

[0030] Furthermore, the cleaning method in S2 includes cleaning with deionized water at least 3 times.

[0031] Furthermore, in S2, the dried nanofiber membrane is immersed in a dopamine solution, and the temperature is set to 25° C.-30° C., the rotation speed is 50 rpm-70 rpm, and the immersion time is 11 h-13 h.

[0032] Furthermore, the incubation conditions in S3 are as follows: the temperature is set at 35° C.-39° C., the rotation speed is 50 rpm-70 rpm, and the incubation time is 23 h-25 h.

[0033] Furthermore, the preparation of the force growth factor solution in S3 specifically includes: dissolving the force growth factor in a Tris-HCl buffer solution, wherein the pH value of the Tris-HCl buffer solution is 10-11.

[0034] Furthermore, the preparation method of the Tris(hydroxymethyl)aminomethane hydrochloride buffer solution is specifically as follows: dispersing Tris(hydroxymethyl)aminomethane hydrochloride) in deionized water, and adjusting the pH value of the Tris(hydroxymethyl)aminomethane hydrochloride buffer solution.

[0035] Furthermore, the molar concentration of the Tris hydrochloride buffer is 9 mM-11 mM.

[0036] Furthermore, the mass concentration of the mechano-growth factor solution in S3 is 490 μg / mL-510 μg / mL.

[0037] Furthermore, after the incubation in S3, drying is required, the drying temperature is 24° C.-26° C., and the drying time is 8 h-12 h.

[0038] The embodiments of the present invention have the following technical effects:

[0039] 1. The present invention uses electrospun nanofiber membrane to continuously deliver force growth factor (MGF). On the one hand, it can simulate the naturally existing biomechanical stimulation, give the remaining periodontal tissue a certain mechanical signal, promote the osteogenic differentiation of periodontal ligament stem cells, and inhibit the osteoclast differentiation of macrophages; on the other hand, it can regulate the local immune microenvironment, by removing the reactive oxygen in the inflammatory environment of the bone defect site, regulating the transformation of macrophages from M1 type (pro-inflammatory type) to M2 type (anti-inflammatory type), providing a good regenerative microenvironment, and effectively promoting the regeneration of periodontal tissue, especially bone tissue. The dopamine layer in the present invention not only serves as a connecting bridge between the force growth factor and the nanofiber membrane, thereby promoting the force growth to be stably loaded on the bracket, which is conducive to the long-term release in the later stage, but also the dopamine layer can improve the hydrophilicity of the bracket, which is conducive to the adhesion of cells to the bracket, thereby promoting the bracket to have a better therapeutic effect. In the present invention, in order to achieve a stable connection between the growth factor and dopamine, the amine group of the polydopamine layer forms an amide bond with the carboxyl group of the force growth factor.

[0040] 2. The present invention aims to provide a nanofiber membrane and its preparation method that can release growth factors stably and long-term, improve the local inflammatory microenvironment, simulate biomechanical signals, promote osteogenic differentiation of stem cells, regulate the osteoblast-osteoclast level, and then mediate bone regeneration in periodontal defect sites.

[0041] 3. The present invention adopts electrospinning technology to prepare nanofiber membranes. The preparation method is simple and the porous structure can simulate the natural extracellular matrix microenvironment, which is beneficial to tissue regeneration. BRIEF DESCRIPTION OF THE DRAWINGS

[0042] In order to more clearly illustrate the specific implementation methods of the present invention or the technical solutions in the prior art, the drawings required for use in the specific implementation methods or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some implementation methods of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0043] Figure 1This is the roughness test result of Comparative Example 1.

[0044] Figure 2 This is the roughness test result of Example 2.

[0045] Figure 3 This is the roughness test result of Example 1.

[0046] Figure 4 It is the comparison result of roughness result data of embodiment and comparative example.

[0047] Figure 5 is the X-ray photoelectron spectrum of the embodiment and the comparative example, wherein, Figure 5 a is the X-ray photoelectron spectrum of Example 1, Figure 5 b is the X-ray photoelectron spectrum of Example 2, Figure 5 c in FIG. 1 is the X-ray photoelectron spectrum of Example 1.

[0048] Figure 6 It is the test result of nitrogen content in the embodiment and comparative example.

[0049] Figure 7 are nanofiber membranes under different conditions, among which Figure 7 Figure a is the nanofiber spun when the injection speed is 1 mL / h, the receiving distance is 18 cm, and the voltage is 12 KV; Figure 7 Figure b is the nanofiber spun when the injection speed is 2 mL / h, the voltage is 15 KV, and the receiving distance is 15 cm; Figure 7 Figure c is the nanofiber spun when the voltage is 15KV, the receiving distance is 18cm, and the injection speed is 1mL / h; Figure 7 Figure d in the figure is the nanofiber spun when the injection speed is 1 mL / h, the receiving distance is 18 cm, and the voltage is 15 KV; Figure 7 Figure e is the nanofiber spun when the injection speed is 2 mL / h, the voltage is 15 KV, and the receiving distance is 18 cm; Figure 7 Figure f is the nanofiber spun when the voltage is 15KV, the receiving distance is 18cm, and the injection speed is 2mL / h; Figure 7 The middle g is the nanofiber spun when the injection speed is 1mL / h, the receiving distance is 18cm, and the voltage is 18KV; Figure 7 h in the middle refers to the nanofibers spun when the injection speed is 2mL / h, the voltage is 15KV, and the receiving distance is 21cm; Figure 7 The i in the figure refers to the nanofibers spun when the voltage is 15KV, the receiving distance is 18cm, and the injection speed is 4mL / h.

[0050] Figure 8 is the bone breaking data, where Figure 8 The middle a is a normal cell; Figure 8 Middle b is the addition of lipopolysaccharide to normal cells; Figure 8 Middle c is the addition of mechano-growth factor to normal cells; Figure 8 Middle d is to add mechano-growth factor to the inflammatory cells caused by lipopolysaccharide; Figure 8 e in the middle is the number of osteoclasts. DETAILED DESCRIPTION

[0051] In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.

[0052] In a first aspect, some embodiments of the present invention provide a nanofiber membrane scaffold for regeneration of periodontal bone defects, wherein the scaffold comprises a nanofiber membrane covered with a polydopamine layer, wherein the surface of the polydopamine layer is loaded with growth factors.

[0053] In the scaffold of the present invention, a force growth factor is loaded on the surface of the nanofiber membrane. The force growth factor can simulate naturally occurring biological stimulation, give certain mechanical signals to the remaining periodontal tissue, promote the osteogenic differentiation of periodontal ligament stem cells, and inhibit the osteoclast differentiation of macrophages; on the other hand, it can regulate the local immune microenvironment, by clearing the active oxygen in the inflammatory environment of the bone defect site and regulating the transformation of macrophages from M1 type (pro-inflammatory type) to M2 type (anti-inflammatory type), thereby providing a good regenerative microenvironment and effectively promoting the regeneration of periodontal tissue, especially bone tissue. In the present invention, in order to promote the continuous and stable delivery of force growth factor on the stent, a polydopamine layer is covered on the nanofiber membrane as a bridge between the force growth factor and the electrospun nanofiber membrane. On the first hand, it can promote the stable loading of the force growth factor on the stent, which is beneficial to the stability of the release rate of the force growth factor; on the second hand, the polydopamine layer can determine the loading rate of the force growth factor on the nanofiber membrane stent, thereby regulating the release rate of the force growth factor on the nanofiber membrane stent, further ensuring that the force growth factor can be released for a long time and stably; on the third hand, polydopamine can increase the hydrophilicity of the stent, which is beneficial to the adhesion of cells to the stent, thereby achieving a better therapeutic effect.

[0054] In some embodiments, the amine groups of the polydopamine layer form amide bonds with the carboxyl groups of the mechano-growth factor.

[0055] In some embodiments, the loading rate of the force growth factor on the nanofiber membrane scaffold is not less than 86%.

[0056] The loading rate of the force growth factor on the nanofiber membrane scaffold of the present invention is not less than 86%, which enables the force growth factor to be released long-term and stably, so that the scaffold of the present invention can achieve the expected therapeutic effect. In the present invention, in order to achieve a loading rate of the force growth factor on the scaffold of not less than 86%, firstly, the force growth factor needs to be stably connected to the dopamine layer, and secondly, the dopamine layer needs to be stably connected to the nanofiber membrane, and finally the technical effect of the present invention can be achieved.

[0057] In some embodiments, the average pore diameter of the nanofiber membrane is 1.4 μm-1.8 μm.

[0058] On the one hand, the nanofiber membrane in the present invention needs to serve as the main structure of the nanofiber membrane support, which requires a certain support strength; on the other hand, the nanofiber membrane also serves as a carrier layer of the polydopamine layer. Polydopamine is covered on the nanofiber membrane. The nanofiber membrane needs to have a suitable pore structure, which is conducive to the loading and release of the force growth factor and prevents pore blockage from blocking the release of the force growth factor. In summary, the average pore diameter of the nanofiber membrane of the present invention is 1.4μm-1.8μm. Typical, non-limiting, for example, the average pore diameter of the electrospun nanofiber membrane is 1.4μm, 1.5μm, 1.6μm, 1.7μm, 1.8μm.

[0059] In a second aspect, some embodiments also provide a method for preparing a nanofiber membrane scaffold for regeneration of periodontal bone defects, the preparation method comprising:

[0060] S1: obtaining an electrospinning solution, injecting the electrospinning solution into a syringe, injecting, preparing a nanofiber membrane by an electrospinning method, and drying the collected nanofiber membrane;

[0061] S2: soaking the dried nanofiber membrane in a dopamine solution, washing, and drying;

[0062] S3: Soak the S2 dopamine-modified nanofiber membrane in a force growth factor solution, incubate, and obtain a nanofiber membrane scaffold.

[0063] In the method of the present invention, the diameter of the nanofiber membrane is controlled by adjusting the parameter conditions in the electrospinning method, so that the nanofiber membrane has a suitable pore size, which is not only beneficial to the overall structural stability of the scaffold, but also beneficial to the stable and continuous release of the force growth factor. In order to further promote the continuous and stable release of the force growth factor, on the one hand, the present invention also builds a bridge polydopamine layer between the nanofiber membrane and the force growth factor, so that the force growth factor can be stably connected to the scaffold. On the other hand, the load of the force growth factor is controlled by the incubation time. On the basis of promoting the stable load of the force growth factor, it also ensures that the force growth factor is continuously and stably released from the pore structure of the scaffold.

[0064] In some embodiments, the preparation of the electrospinning solution includes mixing a first organic polymer material, a second organic polymer material and an organic solvent.

[0065] In some embodiments, the organic solvent includes one or more of N,N-dimethylformamide, dichloromethane, chloroform, deuterated chloroform, tetrahydrofuran, methanol, ethanol, and chloroform.

[0066] In some embodiments, the organic solvent consists of chloroform and methanol; the volume ratio of chloroform to methanol is 5:1.

[0067] In some embodiments, the mass ratio of the first organic polymer material to the second organic polymer material is 7:3.

[0068] In some embodiments, the sum of the mass concentrations of the first organic polymer material and the second organic polymer material in the electrospinning solution is 12%.

[0069] In some embodiments, the first organic polymer material includes polycaprolactone.

[0070] In some embodiments, the second organic polymer material includes one or more of polylactic acid-glycolic acid, polylactic acid, and polyglycolic acid.

[0071] In some embodiments, the injection speed in S1 is 0.9 mL / h-1.1 mL / h; the specific conditions of the electrospinning method in S1 include a voltage of 15 kV-18 kV, a receiving distance of 17 cm-19 cm, a temperature of 24°C-26°C, a humidity of 34%-36%, and an electrospinning time of 0.9 h-1.1 h.

[0072] In the present invention, the selection of voltage, receiving distance and injection speed in the electrospinning method can adjust the diameter of the electrospinning finally obtained, and finally control the pore size of the nanofiber membrane in the present invention.

[0073] In some embodiments, the specific conditions of the electrospinning method in S1 include a voltage of 15 kV, a receiving distance of 18 cm, a temperature of 24° C.-26° C., a humidity of 34%-36%, and an electrospinning time of 0.9 h-1.1 h.

[0074] When the parameter conditions in the electrospinning method are within the above range, the nanofiber membrane obtains a more appropriate pore size, which is not only beneficial to the overall structural stability of the scaffold, but also beneficial to force growth because it can be released stably and continuously.

[0075] In some embodiments, the drying temperature in S1 is 24-26° C., and the drying time is 23-25 ​​hours.

[0076] In some embodiments, the method for preparing the dopamine solution in S2 includes placing dopamine in a tris(hydroxymethyl)aminomethane hydrochloride buffer solution, wherein the pH value of the tris(hydroxymethyl)aminomethane hydrochloride buffer solution is 10-11.

[0077] In some embodiments, the molar concentration of the Tris hydrochloride buffer is 9 mM-11 mM.

[0078] In some embodiments, the mass concentration of dopamine in the dopamine solution is 2 mg / mL.

[0079] In some embodiments, the drying temperature in S2 is 24-26° C., and the drying time is 23-25 ​​hours.

[0080] In some embodiments, the cleaning method in S2 includes cleaning with deionized water at least 3 times.

[0081] In some embodiments, in S2, the dried nanofiber membrane is immersed in a dopamine solution, and the temperature is set to 25° C.-30° C., the rotation speed is 50 rpm-70 rpm, and the immersion time is 11 h-13 h.

[0082] In some embodiments, the incubation conditions in S3 are as follows: the temperature is set at 35° C.-39° C., the rotation speed is 50 rpm-70 rpm, and the incubation time is 23 h-25 h.

[0083] In some embodiments, the preparation of the force growth factor solution in S3 specifically includes: dissolving the force growth factor in a Tris-HCl buffer, wherein the pH value of the Tris-HCl buffer is 10-11.

[0084] In some embodiments, the mass concentration of the mechano-growth factor solution in S3 is 490 μg / mL-510 μg / mL.

[0085] In some embodiments, drying is required after incubation in S3, the drying temperature is 24° C.-26° C., and the drying time is 8 h-12 h. Specific embodiments

[0087] Embodiment 1:

[0088] (1) Organic polymer materials polycaprolactone and polylactic acid-glycolic acid (mass ratio of 7:3) were added to a mixed solution of chloroform / methanol (volume ratio of 5:1) and stirred evenly with a magnetic stirrer at room temperature to obtain an electrospinning solution with a mass concentration of 12%.

[0089] (2) The electrospinning solution obtained in (1) was injected into a 10 mL syringe, and the bubbles in the syringe were emptied. A 21G needle was used. The electrospinning conditions were: voltage 15 KV, flow rate 1 mL / h, receiving distance 18 cm, temperature 25 °C, humidity 35%, aluminum foil was covered on the drum receiver to receive the membrane, and the spinning time was 1 hour. The nanofiber membrane on the aluminum foil was collected, dried in a fume hood overnight, and sealed and stored at room temperature (26 °C) for later use.

[0090] (3) Prepare a 2 mg / mL dopamine solution using 10 mM Tris-HCl solution, pH 10.5, and vortex and sonicate to assist dissolution.

[0091] (4) Immerse the nanofiber membrane in the dopamine solution and shake it at room temperature (60 rpm for 12 h). Take out the nanofiber membrane, wash it three times with double distilled water to completely remove the free dopamine, dry it at 25 °C for 24 h, and store it at 4 °C for later use.

[0092] (5) The dopamine-modified nanofiber membrane was immersed in a mechano-growth factor solution (mass concentration of 500 μg / mL), incubated at 37°C on a shaker (speed of 60 rpm) for 24 h, dried at a drying temperature of 25°C for 10 h, and stored at 4°C for later use. This was recorded as: PCL / PLGA@pDA+MGF.

[0093] Comparative Example 1:

[0094] (1) Organic polymer materials polycaprolactone and polylactic acid-glycolic acid (mass ratio of 7:3) were added to a mixed solution of chloroform / methanol (volume ratio of 5:1) and stirred evenly with a magnetic stirrer at room temperature to obtain an electrospinning solution with a mass concentration of 12%.

[0095] (2) Inject the electrospinning solution obtained in 1 into a 10 mL syringe, empty the bubbles in the syringe, use a 21G needle, and the electrospinning conditions are: voltage 15 KV, flow rate 1 mL / h, receiving distance 18 cm, temperature 25 ° C, humidity 35%, aluminum foil is covered on the roller receiver to receive the membrane, and the spinning time is 1 hour. Collect the nanofiber membrane on the aluminum foil, dry it in a fume hood overnight, and store it at room temperature in a sealed state for later use. Recorded as: PCL / PLGA.

[0096] Comparative Example 2:

[0097] (1) Organic polymer materials polycaprolactone and polylactic acid-glycolic acid (mass ratio of 7:3) were added to a mixed solution of chloroform / methanol (volume ratio of 5:1) and stirred evenly with a magnetic stirrer at room temperature to obtain an electrospinning solution with a mass concentration of 12%.

[0098] (2) Inject the electrospinning solution obtained in 1 into a 10 mL syringe, empty the bubbles in the syringe, use a 21G needle, and the electrospinning conditions are: voltage 15 KV, flow rate 1 mL / h, receiving distance 18 cm, temperature 25 ° C, humidity 35%, aluminum foil is covered on the drum receiver to receive the membrane, and the spinning time is 1 hour. Collect the nanofiber membrane on the aluminum foil, dry it in a fume hood overnight, and store it in a sealed container at room temperature for later use.

[0099] (3) Prepare a 2 mg / mL dopamine solution using 10 mM Tris-HCl solution, pH 10.5, and vortex and sonicate to assist dissolution.

[0100] (4) Immerse the nanofiber membrane in the dopamine solution and shake it at room temperature (60 rpm) overnight. Take out the nanofiber membrane, wash it three times with double distilled water to completely remove the free dopamine, dry it at 25°C for 24 hours, and store it at 4°C for later use. Recorded as: PCL / PLGA@pDA.

[0101] Comparative Example 3:

[0102] (1) Organic polymer materials polycaprolactone and polylactic acid-glycolic acid (mass ratio of 7:3) were added to a mixed solution of chloroform / methanol (volume ratio of 5:1) and stirred evenly with a magnetic stirrer at room temperature to obtain an electrospinning solution with a mass concentration of 12%.

[0103] (2) Inject the electrospinning solution obtained in 1 into a 10 mL syringe, empty the bubbles in the syringe, use a 21G needle, and the electrospinning conditions are: voltage 15 KV, flow rate 1 mL / h, receiving distance 18 cm, temperature 25 ° C, humidity 35%, aluminum foil is covered on the drum receiver to receive the membrane, and the spinning time is 1 hour. Collect the nanofiber membrane on the aluminum foil, dry it in a fume hood overnight, and store it in a sealed container at room temperature for later use.

[0104] (3) The nanofiber membrane was immersed in a mechano-growth factor solution (concentration of 500 μg / mL), incubated at 37°C on a shaker (speed of 60 rpm) for 24 hours, dried at a drying temperature of 25°C for 10 hours, and stored at 4°C for later use. This was recorded as: PCL / PLGA+MGF.

[0105] In the present invention, the stents obtained in the embodiments and comparative examples are also used for testing:

[0106] (1) We used Comparative Example 3 as the control group and Example 1 as the dopamine group, and detected the release of MGF factor 4 hours, 8 hours, 12 hours, 16 hours, 1 day, 3 days, 5 days, 7 days, and 14 days after loading through ELISA experiments.

[0107] Structure and Analysis:

[0108] Table 1 Element contents of samples detected by X-ray photoelectron spectroscopy in the examples and comparative examples

[0109]

[0110] Table 2 Test of release rate of force growth factor in Examples and Comparative Examples

[0111]

[0112] The surface roughness of the stents of Example 1 and Comparative Examples 1-2 was measured using an atomic force microscope. The results are as follows: Figure 1-Figure 4 As shown. Figure 1-Figure 4 It can be found that the surface roughness of Example 1 is significantly higher than that of Comparative Examples 1 and 2. It can be seen that as the amount of material loaded on the surface of the nanofiber membrane increases, the roughness of the scaffold surface increases. This also proves from the side that the nanofiber membrane of the present invention successfully loads the dopamine layer and the force growth factor.

[0113] X-ray photoelectron spectroscopy was used to detect the nitrogen element on the surface of the stents of Example 1 and Comparative Example 1-Comparative Example 2. The results are as follows: Figure 5 As shown in Table 1. Figure 5 (a)- Figure 5 (c) It can be found that the nanofiber membrane obtained in Comparative Example 1 does not contain nitrogen, while both Example 1 and Comparative Example 2 contain nitrogen, and the nitrogen content in Example 1 is significantly higher than that in Comparative Example 2. Both dopamine and MGF contain nitrogen, which can also indirectly prove that the scaffold structure of the present invention contains dopamine and mechano-growth factor. The above results can also be Figure 6 To verify, Figure 6 The results of detecting the surface nitrogen content of Example 1 and Comparative Examples 1-2 by using an energy dispersive X-ray spectrometer.

[0114] In summary, we detected the surface roughness of the samples by atomic force microscopy, and detected the nitrogen content of the samples by X-ray photoelectron spectroscopy and energy dispersive X-ray spectroscopy, proving the successful modification of dopamine and the successful loading of MGF growth factor from two perspectives.

[0115] It is found in Table 2 that at any time point within 14 days, the cumulative release amount and release rate of Example 1 and Comparative Example 3 are higher than those of Example 1, indicating that the release rate of MGF is slowed down after dopamine modification, which is conducive to the long-term release of the factor.

[0116] On this basis, we further studied the nanofiber membrane. The nanofiber membrane is the matrix of the load and also the structural support of the scaffold, which plays an important role in the entire scaffold. By adjusting the parameters in the electrospinning method to control the diameter of the nanofiber membrane, the nanofiber membrane has a suitable pore size, which is not only conducive to the overall structural stability of the scaffold, but also conducive to force growth because it can be released stably and continuously. Therefore, the preparation of the nanofiber membrane was further studied.

[0117] exist Figure 7 It can be found that when the injection speed is controlled to be 1mL / h and the receiving distance is 18cm, the effect of voltage change on the characteristics of nanofibers is studied. When the voltage is 12KV, the fiber orientation (i.e., the neatness of fiber arrangement) is good, but the diameter is small and uneven, and a beaded structure appears, causing the distance between fibers to be closer; when the voltage is 15KV, the nanofiber orientation is good, the fiber thickness is uniform, and there is almost no beaded structure; when the voltage is 18KV, the fiber orientation is poor, the diameter increases, the thickness is uneven, and the overall density is relatively dense.

[0118] When the control voltage is 15KV and the injection speed is 2mL / h, the effect of the receiving distance on the properties of the nanofibers is studied. When the receiving distance is 15cm, the fiber thickness is relatively uniform, but the orientation is poor; when the receiving distance is 18cm, a certain orientation can be seen, but the fiber thickness is uneven and there is a beaded structure; when the receiving distance is increased to 21cm, the fiber orientation is poor and the overall structure is relatively dense.

[0119] When the control voltage is 15KV and the receiving distance is 18cm, the effect of injection speed on the characteristics of nanofibers is studied. When the injection speed is 1mL / h, the fiber thickness is uniform, the pore size is appropriate, and the orientation is good. When the injection speed is 2mL / h, the fiber orientation is poor, a beaded structure appears, and the overall density is relatively dense. When the injection speed is increased to 4mL / h, the fiber orientation is poor, the thickness is uneven, a beaded structure appears, and the arrangement is relatively dense. In summary, combined with the diameter, orientation, pore size and other characteristics of nanofibers, the spinning conditions of voltage of 15KV, injection speed of 1mL / h, and receiving distance of 18cm are further preferred.

[0120] exist Figure 8 (a) shows normal cells. By adding lipopolysaccharide (the amount of lipopolysaccharide added was 100 ng / mL) to normal cells, inflammation was induced in the cells. Figure 8 (b) shows that in the present invention, in normal cells ( Figure 8 (c)) and in inflammatory cells ( Figure 8 (d)) After adding mechanotrophic factor (the amount of mechanotrophic factor added was 40 ng / mL), the results were as follows Figure 8 As shown in (e), mechano-growth factor can inhibit the formation of osteoclasts in normal cells or inflammatory cells.

[0121] In summary, the scaffold of the present invention can continuously deliver force-stimulating growth factors to the periodontal bone defect area for a long time, while exerting anti-inflammatory and osteogenesis-promoting effects, effectively promoting periodontal tissue regeneration and rebuilding periodontal tissue function.

[0122] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art should understand that they can still modify the technical solutions described in the aforementioned embodiments, or replace some or all of the technical features therein by equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the technical solutions of the embodiments of the present invention.

Claims

1. A nanofiber membrane scaffold for regeneration of periodontal bone defects, It is characterized in that The scaffold comprises a nanofiber membrane, the nanofiber membrane is covered with a polydopamine layer, and the surface of the polydopamine layer is loaded with a strong growth factor; The amine group of the polydopamine layer forms an amide bond with the carboxyl group of the mechano-growth factor; The loading rate of the force growth factor in the nanofiber membrane scaffold is not less than 86%.

2. The nanofiber membrane scaffold according to claim 1, It is characterized in that The average pore diameter of the nanofiber membrane is 1.4 μm-1.8 μm.

3. The method for preparing the nanofiber membrane scaffold for regeneration of periodontal bone defects according to any one of claims 1 to 2, It is characterized in that The preparation method comprises: S1: obtaining an electrospinning solution, injecting the electrospinning solution into a syringe, injecting, preparing a nanofiber membrane by an electrospinning method, and drying the collected nanofiber membrane; S2: soaking the dried nanofiber membrane in a dopamine solution, washing, and drying; S3: soaking the dopamine-modified nanofiber membrane in S2 in a force growth factor solution, and incubating the solution so that the amine groups of the polydopamine layer obtained in S2 form amide bonds with the carboxyl groups of the force growth factor; The incubation conditions in S3 are as follows: the temperature is set at 35° C.-39° C., the rotation speed is 50 rpm-70 rpm, and the incubation time is 23 h-25 h.

4. The preparation method according to claim 3, It is characterized in that The preparation of the electrospinning solution comprises mixing a first organic polymer material, a second organic polymer material and an organic solvent; The organic solvent includes one or more of N,N-dimethylformamide, dichloromethane, chloroform, deuterated chloroform, tetrahydrofuran, methanol, ethanol, and chloroform; The first organic polymer material includes polycaprolactone; The second organic polymer material includes one or more of polylactic acid-glycolic acid, polylactic acid, and polyglycolic acid; The mass ratio of the first organic polymer material to the second organic polymer material is 7:3; The sum of the mass concentrations of the first organic polymer material and the second organic polymer material in the electrospinning solution is 12%.

5. The preparation method according to claim 3, It is characterized in that The injection speed in S1 is 0.9 mL / h-1.1 mL / h; The specific conditions of the electrospinning method in S1 include a voltage of 15 kV-18 kV, a receiving distance of 17 cm-19 cm, a temperature of 24° C.-26° C., a humidity of 34%-36%, and an electrospinning time of 0.9 h-1.1 h.

6. The preparation method according to claim 3, It is characterized in that The preparation method of the dopamine solution in S2 comprises placing dopamine in a tris(hydroxymethyl)aminomethane hydrochloride buffer solution, wherein the pH value of the tris(hydroxymethyl)aminomethane hydrochloride buffer solution is 10-11; The mass concentration of dopamine in the dopamine solution is 2 mg / mL.

7. The preparation method according to claim 3, It is characterized in that In the step S2, the dried nanofiber membrane is immersed in a dopamine solution, and the temperature is set to 25° C.-30° C., the rotation speed is 50 rpm-70 rpm, and the immersion time is 11 h-13 h.

8. The preparation method according to claim 3, It is characterized in that The mass concentration of the input growth factor solution in S3 is 490 μg / mL-510 μg / mL; The preparation of the growth factor solution specifically includes: dissolving the mechano-growth factor in a tris-hydroxymethylaminomethane hydrochloride buffer solution, wherein the pH value of the tris-hydroxymethylaminomethane hydrochloride buffer solution is 10-11.

9. Use of the nanofiber membrane scaffold for regeneration of periodontal bone defects as described in any one of claims 1 to 2 in the preparation of a drug for treating periodontal bone defects.

Citation Information

Patent Citations

  • Lactic acid porous fiber membrane and application thereof

    CN115058892A